Skip to content

Efficacy and safety of MYODISC defocusing lenses in delaying the progression of myopia in children

Efficacy and safety of MYODISC defocusing lenses in delaying the progression of myopia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111582
Enrollment
Unknown
Registered
2025-11-03
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

MYODISC defocusing lenses group:Wearing MYODISC defocusing lenses all day
Single vision lens (SVL) group:Wearing SVL lenses all day

Sponsors

Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1. Age between 8 and 13 years; 2. No restriction on gender; 3. Spherical equivalent refractive error between –1.00 and –5.75 D; 4. Astigmatism <= –1.50 D; 5. Anisometropia <= 1.00 D; 6. Best-corrected visual acuity in each eye not worse than 20/20; 7. Strabismus angle not exceeding 20?; 8. Adequate cognitive function to cooperate with examinations; 9. Willingness to participate in follow-up visits; 10. Willingness to participate in this study and provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Restricted activity due to medical illness, medication, or emotional state; 2. With organic diseases of the eye or other body systems; 3. History of ocular surgery; 4. Concurrent use of other medications that may affect vision; 5. Worn contact lenses within the past month; 6. Used other myopia control methods within the past year (e.g., other defocus lenses, progressive lenses, bifocal lenses, bifocal prisms, orthokeratology lenses, defocus soft contact lenses, defocus RGP lenses, atropine, etc.); 7. Participated in other studies that may directly or indirectly influence clinical outcomes within the past month; 8. Subjects unable to communicate or follow study instructions; 9. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Axial length;

Secondary

MeasureTime frame
Spherical equivalent;Uncorrected Visual Acuity;Presenting Visual Acuity;Best Corrected Visual Acuity;

Countries

China

Contacts

Public ContactTan Qingqing

Department of Ophthalmology, Affiliated Hospital of North Sichuan Medical College

qqtan@nsmc.edu.cn+86 138 9083 4742

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026